摘要
目前国内外均无有关病例报告伦理审查的法律法规、伦理准则和监管要求,病例报告是否需要伦理审查,在不同地区、不同国家、不同医疗机构存在不同的规范,国内外不同期刊的规定也不一致。通过对病例报告发表是否需要伦理审查批准的讨论,总结当前病例报告发表存在隐私保护和知情同意的问题,提出病例报告伦理审查要点,包括病例报告的科学性,患者隐私保护,知情同意以及利益冲突管理,以使病例报告合乎伦理规范,促进医学科学发展。
At present, there are no laws and regulations, ethical standards, and regulatory requirements related to ethical review of case reports at home and abroad. Whether ethical review is required for case reports, there are different norms in different regions, countries and medical institutions, and the provisions of different journals at home and abroad are also inconsistent. Through the discussion on whether the publication of case reports needs ethical review and approval, this paper summarized the problems of privacy protection and informed consent existing in the publication of case reports, and proposed the key points of ethical review of case reports, including the scientific nature of case reports, patient privacy protection, informed consent and conflict of interest management, with a view to making case reports conform to ethical standards and promoting the development of medical science.
作者
刘丹
周吉银
LIU Dan;ZHOU Jiyin(Institution of National Drug Clinical Trial,the Second Affiliated Hospital of Army Medical University,Chongqing 400037,China)
出处
《中国医学伦理学》
2023年第2期193-199,共7页
Chinese Medical Ethics
基金
2020年陆军军医大学人文社会科学基金一般项目“我国临床研究利益冲突管理的现状与对策研究”(2020XRW10)
2019年陆军军医大学人文社会科学基金重点项目“伦理倾销对我国的危害及防范研究”(2019XRW04)。
关键词
病例报告
伦理审查
隐私保护
知情同意
Case Report
Ethical Review
Privacy Protection
Informed Consent